With liraglutide, for example, participants who were 30 years old reduced their weight by 10.1 kg (22.3 lb) over 52 weeks, whereas those age 60 showed a reduction of just 3.31 kg (7.3 lb).

Approximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming changes at CVS that may make getting the drug harder and pricier.

Although Pusztai and his oncology peers at Yale don't yet use GPL-1 agonists, Neil Iyengar, MD, and colleagues have begun doing so to help some patients with breast cancer manage their weight.

It's a widely held belief that you can't mix GPL code and code covered by other open source licenses. While there are restrictions, it is actually possible in both GPLv2 and GPLv3. New language in ...

Comparing GPL-1 Receptor Agonists for Weight Reduction – Assessing efficacy, safety, and 'potential influencing factors' by Diana Swift , Contributing Writer, MedPage Today June 10, 2025 • 3 ...